IF

InnoBio Fund

Europe, Ile-de-France, France, Maisons-alfort

Description

InnoBio is a French venture capital fund.

Investor Profile

InnoBio Fund has made 13 investments, with 0 in the past 12 months and 15% as lead.

Stage Focus

  • Series Unknown (31%)
  • Series C (23%)
  • Series A (15%)
  • Series B (15%)
  • Series D (8%)
  • Post Ipo Equity (8%)

Country Focus

  • France (92%)
  • United States (8%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Medical Device
  • Health Care
  • Health Diagnostics
  • Biopharma
  • Life Science
  • Information Technology
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does InnoBio Fund frequently co-invest with?

Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 4
IRDI
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 1
Cemag Invest
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Idinvest Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 3
Amundi Private Equity Funds
Europe, Ile-de-France, France, Paris
Co-Investments: 3
IXO Private Equity
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 1
Auriga Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2

What are some of recent deals done by InnoBio Fund?

AlgoTherapeutix

Suresnes, Ile-de-France, France

AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.

BiotechnologyInformation TechnologyPharmaceutical
Series BMar 14, 2023
Amount Raised: $21,453,404
Millendo Therapeutics

Ann Arbor, Michigan, United States

Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases.

BiotechnologyLife ScienceTherapeutics
Series UnknownAug 9, 2018
Amount Raised: $30,000,000
Advicenne

Paris, Ile-de-France, France

Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare kidney diseases.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series UnknownMar 20, 2017
Amount Raised: $17,179,197
TxCell

Valbonne, Provence-Alpes-Cote d'Azur, France

TxCell develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases.

BiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityFeb 24, 2017
Amount Raised: $11,610,503
Sensorion

Clapiers, Languedoc-Roussillon, France

Sensorion is a France-based biopharmaceutical company developing targeted therapeutic solutions for the treatment of vestibular deficits.

BiopharmaBiotechnologyHealth CareTherapeutics
Series UnknownJan 21, 2015
Amount Raised: $4,645,782
Pixium Vision

Paris, Ile-de-France, France

Pixium Vision develops retinal implant systems for patients who have lost their eyesight.

Clinical TrialsHealth CareInformation TechnologyMedical DeviceSoftware
Series ANov 25, 2013
Amount Raised: $20,279,369
Genticel

Paris, Ile-de-France, France

Gentiel develops therapeutic vaccines for the prevention of cervical cancer in HPV infected women.

BiotechnologyMedical DeviceTherapeutics
Series DApr 24, 2013
Amount Raised: $23,682,652
Poxel

Lyon, Rhone-Alpes, France

Poxel is a research integrated pharmaceutical company that develops products for metabolic diseases.

BiotechnologyHealth DiagnosticsPharmaceutical
Series BDec 18, 2012
Amount Raised: $17,186,946
TxCell

Valbonne, Provence-Alpes-Cote d'Azur, France

TxCell develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases.

BiotechnologyPharmaceuticalTherapeutics
Series CNov 26, 2012
Amount Raised: $16,088,080
DBV Technologies

Bagneux, Ile-de-France, France

DBV Technologies focuses on the development of innovative products for the diagnosis and treatment of food allergies.

BiopharmaBiotechnologyHealth CareHealth Diagnostics
Series CJan 5, 2011
Amount Raised: $25,500,000